Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction

Carmine Rocca(University of Calabria), Tommaso Angelone(Istituto Nazionale di Economia Agraria)
International Immunopharmacology
February 23, 2021
Cited by 27


Related Papers